| Heart disease and stroke statistics—2020 update: a report from the American Heart Association SS Virani, A Alonso, EJ Benjamin, MS Bittencourt, CW Callaway, ... Circulation 141 (9), e139-e596, 2020 | 17396* | 2020 |
| Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes PR Schauer, DL Bhatt, JP Kirwan, K Wolski, A Aminian, SA Brethauer, ... New England Journal of Medicine 376 (7), 641-651, 2017 | 2725 | 2017 |
| Heart disease and stroke statistics—2023 update: a report from the American Heart Association CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson, P Arora, CL Avery, ... Circulation 147 (8), e93-e621, 2023 | 2517 | 2023 |
| Diabetic kidney disease: a report from an ADA Consensus Conference KR Tuttle, GL Bakris, RW Bilous, JL Chiang, IH De Boer, ... Diabetes care 37 (10), 2864-2883, 2014 | 1930 | 2014 |
| Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes PR Schauer, DL Bhatt, JP Kirwan, K Wolski, SA Brethauer, ... New England Journal of Medicine 370 (21), 2002-2013, 2014 | 1924 | 2014 |
| KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease IH de Boer, ML Caramori, JCN Chan, HJL Heerspink, C Hurst, K Khunti, ... Kidney international 98 (4), S1-S115, 2020 | 644 | 2020 |
| Metabolic syndrome and kidney disease: a systematic review and meta-analysis G Thomas, AR Sehgal, SR Kashyap, TR Srinivas, JP Kirwan, ... Clinical journal of the American Society of Nephrology 6 (10), 2364-2373, 2011 | 636 | 2011 |
| Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis N Tangri, ME Grams, AS Levey, J Coresh, LJ Appel, BC Astor, G Chodick, ... Jama 315 (2), 164-174, 2016 | 630 | 2016 |
| American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson, P Arora, CL Avery, ... Heart disease and stroke statistics-2023 update: a report from the American …, 2023 | 616 | 2023 |
| Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials GFM Strippoli, SD Navaneethan, DW Johnson, V Perkovic, F Pellegrini, ... Bmj 336 (7645), 645-651, 2008 | 548 | 2008 |
| HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis SC Palmer, SD Navaneethan, JC Craig, DW Johnson, V Perkovic, ... Cochrane Database of Systematic Reviews, 2014 | 512* | 2014 |
| Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease SC Palmer, SD Navaneethan, JC Craig, DW Johnson, M Tonelli, AX Garg, ... Annals of internal medicine 153 (1), 23-33, 2010 | 476 | 2010 |
| Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis SD Navaneethan, H Yehnert, F Moustarah, MJ Schreiber, PR Schauer, ... Clinical journal of the American Society of Nephrology 4 (10), 1565-1574, 2009 | 455 | 2009 |
| 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association SS Martin, AW Aday, ZI Almarzooq, CAM Anderson, P Arora, CL Avery, ... Circulation 149 (8), e347-e913, 2024 | 452 | 2024 |
| Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference CM Clase, JJ Carrero, DH Ellison, ME Grams, BR Hemmelgarn, ... Kidney international 97 (1), 42-61, 2020 | 419 | 2020 |
| Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis SC Palmer, JC Craig, SD Navaneethan, M Tonelli, F Pellegrini, ... Annals of internal medicine 157 (4), 263-275, 2012 | 417 | 2012 |
| Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials P Kandula, M Dobre, JD Schold, MJ Schreiber Jr, R Mehrotra, ... Clinical Journal of the American Society of Nephrology 6 (1), 50-62, 2011 | 403 | 2011 |
| Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease GFM Strippoli, C Bonifati, ME Craig, SD Navaneethan, JC Craig The Cochrane database of systematic reviews 2006 (4), 2006 | 362 | 2006 |
| Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence P Rossing, ML Caramori, JCN Chan, HJL Heerspink, C Hurst, K Khunti, ... Kidney international 102 (5), 990-999, 2022 | 350* | 2022 |
| Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis SD Navaneethan, SU Nigwekar, AR Sehgal, GFM Strippoli Clinical Journal of the American Society of Nephrology 4 (3), 542-551, 2009 | 324 | 2009 |
